RE:RE:New Press Release - Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trialexactly as notable has been saying "accelerated approval"
will be a good day.
The shorters will try, but overall, this is blockbuster news.
&
we dont yet have the FDA update on the MBC trial.
more good to come.'
I did caution those dimwhits not to short.
Oh well....better comver today, or you can wiait until next announcment and will cost much much more.
Im busy today, but will lool in.
The pancan....modification says clearly "leads directly to market"
Reminder pancratic cancer is dadly & fast.
MeaningANY imporvement will be accepted as a new standard of care.